PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 52 filers reported holding PMV PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $82,821 | -30.5% | 51,124 | +168.5% | 0.00% | – |
| Q2 2023 | $119,197 | -90.3% | 19,041 | -92.6% | 0.00% | -100.0% |
| Q1 2023 | $1,223,806 | +674.3% | 256,563 | +1312.2% | 0.01% | +400.0% |
| Q4 2022 | $158,062 | -66.6% | 18,168 | -54.3% | 0.00% | -50.0% |
| Q3 2022 | $473,000 | +21.0% | 39,771 | +44.8% | 0.00% | 0.0% |
| Q2 2022 | $391,000 | -44.9% | 27,471 | -19.3% | 0.00% | -33.3% |
| Q1 2022 | $709,000 | +11.8% | 34,056 | +24.0% | 0.00% | +50.0% |
| Q4 2021 | $634,000 | -19.4% | 27,455 | +23.9% | 0.00% | -81.8% |
| Q3 2020 | $787,000 | – | 22,156 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |